Skip to content

Effectiveness Trial of the French Blues Indicated Depression Prevention Program

Pilot Effectiveness Trial of the French Blues Indicated Depression Prevention Program

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02731053
Acronym
French Blues
Enrollment
72
Registered
2016-04-07
Start date
2016-03-31
Completion date
2016-11-30
Last updated
2017-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Prevention, Adolescents, School, Effectiveness

Brief summary

The purpose of this pilot study is to test the effectiveness of French adaptation of the Blues program, a school-based indicated depression prevention intervention. The program will be delivered by the endogenous psycho-social staff of 3 Montreal secondary schools to adolescents with sub-clinical depressive symptoms and compared to a no-intervention (Informational Brochure only) control condition, designed to represent the usual intervention in these schools.

Interventions

BEHAVIORALBlues program

Participants will attend 6 weekly 1-hour sessions of group cognitive-behavioral therapy administered by school staff, and will do home practice between sessions and after the program individually using a web site (called the Blues App)

Sponsors

Université de Montréal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Elevated depressive symptoms (score of 20 or above on the Center for Epidemiological Studies - Depression screening questionnaire)

Exclusion criteria

* Current major depression diagnosis * Current active suicidal behaviors * Being in a special school curriculum for academic or behavioral problems

Design outcomes

Primary

MeasureTime frame
Number of participants who develop a major depressive episode as measured using the SCID diagnostic interview (posttest, 6 month follow-up)6 months
Change in depressive symptoms as measured using continuous SCID scores (baseline, posttest, 6-month follow-up)6 months
Change in depressive symptoms as measured using the CES-D questionnaire (baseline, posttest, 6-month follow-up)6 months
Change in depressive symptoms as measured using the PHQ-9 questionnaire (baseline, posttest, 6-month follow-up)6 months

Secondary

MeasureTime frame
Change in substance use as measured using a scale from the MASPAQ questionnaire (Leblanc, 1996) (baseline, posttest, 6-month follow-up)6 months
Change in anxiety symptoms as measured using the SCAS questionnaire (baseline, posttest, 6-month follow-up)6 months
Change in delinquent behaviors as measured using a scale from the MASPAQ questionnaire (Leblanc, 1996) (baseline, posttest, 6-month follow-up)6 months
Change in parent-child relationship as measured using a scale from the MASPAQ questionnaire (Leblanc, 1996) (baseline, posttest, 6-month follow-up)6 months
Change in social adjustment as measured using Évaluation sociale de Soi chez les jeunes adultes questionnaire (Michaud et al., 2006) (baseline, posttest, 6-month follow-up)6 months
Change in affective school engagement as measured using a subscale of the school engagement questionnaire (Archambault et al., 2009) (baseline, posttest, 6-month follow-up)6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026